相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anthracycline-containing regimens or taxane versus S-1 as first-line chemotherapy for metastatic breast cancer
Hirofumi Mukai et al.
BRITISH JOURNAL OF CANCER (2021)
Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study
Tahira Devji et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer
Jammbe Z. Musoro et al.
JNCI CANCER SPECTRUM (2019)
Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases
Srinivas Raman et al.
QUALITY OF LIFE RESEARCH (2018)
Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol
Zebedee Jammbe Musoro et al.
BMJ OPEN (2018)
An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D
Yan Feng et al.
QUALITY OF LIFE RESEARCH (2017)
Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapy
Fanxing Hong et al.
BMC CANCER (2013)
Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30
K. Cocks et al.
EUROPEAN JOURNAL OF CANCER (2012)
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients
J. Maringwa et al.
ANNALS OF ONCOLOGY (2011)
Evidence-Based Guidelines for Determination of Sample Size and Interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30
Kim Cocks et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials
John T. Maringwa et al.
SUPPORTIVE CARE IN CANCER (2011)
The Missing Voice of Patients in Drug-Safety Reporting
Ethan Basch
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Oral Uracil and Tegafur Compared With Classic Cyclophosphamide, Methotrexate, Fluorouracil As Postoperative Chemotherapy in Patients With Node-Negative, High-Risk Breast Cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial
Toru Watanabe et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes
Ethan Basch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
Dennis Revicki et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
分享论文
